Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0KM3P
|
||||
| Former ID |
DIB004831
|
||||
| Drug Name |
NOStentin
|
||||
| Synonyms |
NOStentin; Gene therapy (restenosis); Gene therapy (iNOS), Cardion; Gene therapy (restenosis), Cardion
|
||||
| Indication | Restenosis [ICD10:I51.89] | Discontinued in Phase 1 | [547127] | ||
| Company |
Stanford University
|
||||
| Target and Pathway | |||||
| Target(s) | Nitric oxide synthase, inducible | Target Info | Modulator | [527754] | |
| BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
| KEGG Pathway | Arginine biosynthesis | ||||
| Arginine and proline metabolism | |||||
| Metabolic pathways | |||||
| Calcium signaling pathway | |||||
| HIF-1 signaling pathway | |||||
| Peroxisome | |||||
| Salmonella infection | |||||
| Pertussis | |||||
| Leishmaniasis | |||||
| Chagas disease (American trypanosomiasis) | |||||
| Toxoplasmosis | |||||
| Amoebiasis | |||||
| Tuberculosis | |||||
| Pathways in cancer | |||||
| Small cell lung cancer | |||||
| NetPath Pathway | IL1 Signaling Pathway | ||||
| IL2 Signaling Pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.